PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.\', \'Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.\', \'Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK.\', \'Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'National Infection Service, Public Health England, Salisbury, UK.\', \'Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'UK Biocentre, Milton Keynes, UK.\', \'Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.\', \'Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.\', \'NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.\', \'University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.\', \'St George\'s Vaccine Institute, St George\'s, University of London, London, UK.\', \'Department of Infection, Guy\'s and St Thomas\' NHS Foundation Trust, St Thomas\' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.\', \'Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.\', \'NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'University of Glasgow, Glasgow, UK; Lighthouse Laboratory in Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.\', \'Severn Pathology, North Bristol NHS Trust, Bristol, UK.\', \'NIHR UCLH Clinical Research Facility, London, UK; NIHR UCLH Biomedical Research Centre, London, UK.\', \'Hull University Teaching Hospitals NHS Trust, Hull, UK.\', \'London Northwest University Healthcare, Harrow, UK.\', \'NIHR Imperial Clinical Research Facility, London, UK; NIHR Imperial Biomedical Research Centre, London, UK.\', \'College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK.\', \'Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.\', \'MRC University of Glasgow Centre for Virus Research, Glasgow, UK; Severn Pathology, North Bristol NHS Trust, Bristol, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.\', \'Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK; Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.\', \'University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK.\', \'AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA.\', \'Public Health Wales, Cardiff, UK; Aneurin Bevan University Health Board, Newport, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0140-6736(21)00628-010.1016/S0140-6736(21)00628-0
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33798499
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all